ask="N/A"
ask_size="N/A"
average_daily_volume="8900"
bid="1.0400"
bid_size="500"
book_value="0.9330"
change="+0.0575"
change_from_200_day_moving_average="-1.2127"
change_from_50_day_moving_average="-0.8320"
change_from_52_week_high="-3.5325"
change_From_52_week_low="0.3275"
change_in_percent="+3.4639%"
close="1.7175"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.4260"
ebitda="-13.03M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.0700"
eps_estimate_next_year="-0.3300"
ex_dividend_date="N/A"
float_shares="23126000"
high="1.8360"
high_52_weeks="5.2500"
last_trade_date="3/7/2017"
last_trade_price="1.7175"
last_trade_size="1000"
last_trade_time="10:31am"
low="1.6500"
low_52_weeks="1.3900"
market_capitalization="61.38M"
moving_average_200_day="2.9302"
moving_average_50_day="2.5495"
name="Oasmia Pharmaceutical AB"
notes="N/A"
one_year_target_price="6.0000"
open="1.6500"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-41.3871%"
percent_change_from_50_day_moving_average="-32.6336%"
percent_change_from_52_week_high="-67.2857%"
percent_change_from_52_week_low="+23.5612%"
previous_close="1.6600"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.7792"
price_per_sales="33.2571"
revenue="1.78M"
shares_outstanding="35736000"
short_ratio="0.3500"
stock_exchange="NCM"
symbol="OASM"
volume="4829"
weeks_range_52="1.3900 - 5.2500"
